A phase II study of capecitabine and cisplatin (XP) as first-line chemotherapy in patients with advanced esophageal squamous cell carcinoma

Author： Lee Jeeyun   Im Young-Hyuck   Cho Eun   Hong Yong   Lee Hyo   Kim Hyo   Kim Mi-Jin   Kim Kwhanmien   Kang Won   Park Keunchil   Shim Young  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.62, Iss.1, 2008-06, pp. : 77-84

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

A multicenter phase II study of biweekly capecitabine in combination with oxaliplatin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer

By Chao Yee   Hsieh Jan-Sing   Yeh Hsien-Tang   Su Yu-Chieh   Wu Cheng-Chung   Chen Jen-Shi   Tai Cheng-Jeng   Bai Li-Yuan   Yeh Kun-Huei   Su Wu-Chou   Li Chung-Pin  

Cancer Chemotherapy and Pharmacology, Vol. 73, Iss. 4, 2014-04 ,pp. : 799-806

Springer Publishing Company

Access to resources Recommend Favorite

Chronomodulated administration of oxaliplatin plus capecitabine (XELOX) as first line chemotherapy in advanced colorectal cancer patients: phase II study

By Santini Daniele   Vincenzi Bruno   Schiavon Gaia   Di Seri Marisa   Virzí Vladimir   Spalletta Bruno   Caricato Marco   Coppola Roberto   Tonini Giuseppe  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 5, 2007-04 ,pp. : 613-620

Springer Publishing Company

Access to resources Recommend Favorite

Biweekly docetaxel, cisplatin, and 5-fluorouracil (DCF) chemotherapy for advanced esophageal squamous cell carcinoma: a phase I dose-escalation study

By Tanaka Yoshihiro   Yoshida Kazuhiro   Sanada Yuichi   Osada Shinji   Yamaguchi Kazuya   Takahashi Takao  

Cancer Chemotherapy and Pharmacology, Vol. 66, Iss. 6, 2010-11 ,pp. : 1159-1165

Springer Publishing Company

Access to resources Recommend Favorite

A Phase II Study of Gemcitabine and Cisplatin in Patients with Advanced, Persistent, or Recurrent Squamous Cell Carcinoma of the Cervix

By Burnett A.F.   Roman L.D.   Garcia A.A.   Muderspach L.I.   Brader K.R.   Morrow C.P.  

Gynecologic Oncology, Vol. 76, Iss. 1, 2000-01 ,pp. : 63-66

Elsevier

Access to resources Recommend Favorite

Multicenter phase II study of oral capecitabine plus irinotecan as first-line chemotherapy in advanced colorectal cancer: A Korean Cancer Study Group Trial

By Kim Tae Won   Kang Won Ki   Chang Heung Moon   Park Joon Oh   Ryoo Baek Yeol   Ahn Jin Seok   Zang Dae Young   Lee Kyung Hee   Kang Yoon Koo   Kim Sung Rok   Kim Hoon-Kyo  

Acta Oncologica, Vol. 44, Iss. 3, 2005-05 ,pp. : 230-235

Informa Healthcare

Access to resources Recommend Favorite